News

Published on 24 Nov 2021 on Entrpreneur

Buy the Dip in These 3 Healthcare Stocks Right Now


Article preview image

A confluence of the widespread adoption of digital innovations, accelerating developments in therapeutics, and rising healthcare spending should propel...

NYSE.ABT price evolution
NYSE.XLK price evolution
NYSE.XLV price evolution
NYSE.A price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Is a Surprise Coming for Abbott (ABT) This Earnings Season?

Investors are always looking for stocks that are poised to beat at earnings season and Abbott Lab...

Zacks via Yahoo Finance 24 Jan 2022

Abbott’s share price soared as COVID-19 testing demand surged. Here’s what that may mean for the...

Abbott Laboratories Inc.’s stock hit a 10-year high of $141.46 on Dec. 27 at the same time that p...

MarketWatch 24 Jan 2022

3 Things About Abbott Laboratories That Smart Investors Know

When it comes to underrated healthcare stocks that smart investors love, Abbott Laboratories (NYS...

Motley Fool 21 Jan 2022

Rise in COVID-19 Test Demand to Boost Abbott (ABT) Q4 Earnings

Abbott Laboratories ABT is slated to report fourth-quarter and full-year 2021 results on Jan 26, ...

Zacks via Yahoo Finance 21 Jan 2022

Abbott (ABT) Stock Moves -1.06%: What You Should Know

In the latest trading session, Abbott (ABT) closed at $124.71, marking a -1.06% move from the pre...

Zacks via Yahoo Finance 21 Jan 2022

Abbott's (ABT) Organic Base Sales Grow Amid COVID Case Surge

Abbott Laboratories ABT has been delivering consistent organic growth in the Established Pharmace...

Zacks via Yahoo Finance 18 Jan 2022

Will Abbott Laboratories Be a Trillion-Dollar Stock by 2035?

In the unlikely event that someone's never heard of it, Abbott Laboratories (NYSE: ABT) is one of...

Motley Fool 18 Jan 2022

Will Demand for Rapid COVID-19 Tests Help Abbott Laboratories Beat the Market in 2022?

In particular, Abbott Laboratories (NYSE: ABT) makes BinaxNOW kits, which are the most popular ra...

Motley Fool 16 Jan 2022

Will Demand for Rapid COVID-19 Tests Help Abbott Laboratories Beat the Market in 2022? | The Motley...

If you've walked around your local pharmacy recently, you know that at-home coronavirus testing k...

The Motley Fool 16 Jan 2022

Here's Why ShockWave Medical Stock Is Perking Up This Week

Shares of the medtech company ShockWave Medical (NASDAQ: SWAV) rose by as much as 11.2% during th...

Motley Fool 14 Jan 2022